Improving Personal Recovery After Depression with a Blended Module (STAIRS)
NCT05440812 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2024-12-10
Summary
Almost all mental healthcare treatments of depression focus on symptomatic recovery. However, such recovery does not inherently mean that personal recovery is reached. In fact, many persons still experience functional impairments after symptomatic recovery. As this has a negative influence on daily life, a new blended module (STAIRS) was developed to promote personal recovery in persons that are in the final stage of symptomatic recovery from depression. The current study will investigate the efficacy of STAIRS, by adding STAIRS to care as usual and comparing it with care as usual. It is hypothesized that STAIRS will have a positive effect on personal recovery and that this effect is larger than in the control group.
Conditions
Interventions
- BEHAVIORAL
-
Storytelling and Training to Advance Individual Recovery Skills (STAIRS)
STAIRS is a 8-week program, in which 8 different themes are addressed. Coverage of each theme starts with a group meeting guided by a professional and expert by experience. In these meetings different exercises are done (e.g., filling out an actual and desired week-schedule, role-playing a difficult situation), information is given and experiences are shared. Between meetings, participants can choose from a range of homework exercises to practice their desired skills in a tailored way. In addition, participants can share experiences with the other group members and exchange reactions using a private online community.
Sponsors & Collaborators
-
Hanze University of Applied Sciences
collaborator UNKNOWN -
University Medical Center Groningen
lead OTHER
Principal Investigators
-
Robert Schoevers, prof · UMCG
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-11
- Primary Completion
- 2025-05-31
- Completion
- 2025-05-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
NCT00578669 ·Status: COMPLETED ·Phase: PHASE3
-
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
NCT03310281 ·Status: COMPLETED ·Phase: NA
-
Fluoxetine vs. Brief Psychotherapy for Major Depression
NCT00714779 ·Status: COMPLETED ·Phase: NA
-
Can Immediate Post-injury Fluoxetine Improve the Recovery Trajectories of Victims in Bodily Trauma?
NCT06046859 ·Status: RECRUITING ·Phase: PHASE4
-
SSRIs vs. TCAs for Depression in ALS Patients
NCT02851914 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Friendship Bench Plus Trial
NCT06384209 ·Status: RECRUITING ·Phase: NA
-
Dementia Antipsychotics And Antidepressants Discontinuation Study
NCT00594269 ·Status: COMPLETED ·Phase: PHASE4
-
Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis
NCT00004300 ·Status: SUSPENDED ·Phase: PHASE2
-
Prevention of Recurrence in Depression With Drugs and CT
NCT00057577 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Depression Interventions After Acute Coronary Syndrome
NCT01032018 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Repetitive Behavior Disorders in People With Severe Mental Retardation
NCT00491478 ·Status: UNKNOWN ·Phase: PHASE3
-
Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors
NCT00296517 ·Status: COMPLETED ·Phase: PHASE3
-
Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
NCT02185131 ·Status: COMPLETED ·Phase: PHASE2
-
Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression
NCT00928980 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Inquiry Based Stress Reduction (IBSR) for Depression, a Clinical Trial
NCT02542618 ·Status: UNKNOWN ·Phase: NA
-
Cognitive and Drug Therapy for Drug-Resistant Depression
NCT00000376 ·Status: COMPLETED ·Phase: NA
-
Wellbutrin XL Effects on SSRIs Induced Changes
NCT00456820 ·Status: COMPLETED ·Phase: PHASE4
-
Cognitive Therapy for Recurrent Depression
NCT00118404 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Sertraline to Prevent PTSD
NCT00182078 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
NCT00125957 ·Status: COMPLETED ·Phase: PHASE3
-
The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD
NCT02473783 ·Status: COMPLETED ·Phase: PHASE2
-
Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania
NCT00118014 ·Status: COMPLETED ·Phase: PHASE4
-
Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone
NCT02900092 ·Status: COMPLETED ·Phase: NA
-
Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse
NCT00612313 ·Status: COMPLETED ·Phase: NA
-
STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse
NCT00369746 ·Status: COMPLETED